Instituto Rosenbusch S.A. (ROSE.BA)
Buenos Aires · ARS · Healthcare · Drug Manufacturers - Specialty & Generic
ARS 135.00 (-0.37%) as of
Key statistics
- Market cap
- 5.75B
- P/E (TTM)
- 0.72
- EPS (TTM)
- 188.70
- Dividend yield
- 0.00%
- 52-week range
- 127.00 – 357.00
- Beta
- 0.03
- Revenue (TTM)
- 6.81B
- Profit margin
- 2.69%
- Volume
- 6.34k
About Instituto Rosenbusch S.A.
Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals. The company was founded in 1917 and is based in Buenos Aires, Argentina.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Buenos Aires, Argentina
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.